Literature DB >> 29672073

Positive clinical psychology and Schema Therapy (ST): The development of the Young Positive Schema Questionnaire (YPSQ) to complement the Young Schema Questionnaire 3 Short Form (YSQ-S3).

John P Louis1, Alex M Wood1, George Lockwood2, Moon-Ho Ringo Ho3, Eamonn Ferguson4.   

Abstract

Negative schemas have been widely recognized as being linked to psychopathology and mental health, and they are central to the Schema Therapy (ST) model. This study is the first to report on the psychometric properties of the Young Positive Schema Questionnaire (YPSQ). In a combined community sample (Manila, Philippines, n = 559; Bangalore, India, n = 350; Singapore, n = 628), we identified a 56-item, 14-factor solution for the YPSQ. Multigroup confirmatory factor analysis supported the 14-factor model using data from two other independent samples: an Eastern sample from Kuala Lumpur, Malaysia (n = 229) and a Western sample from the United States (n = 214). Construct validity was demonstrated with the Young Schema Questionnaire 3 Short Form (YSQ-S3) that measures negative schemas, and divergent validity was demonstrated for 11 of the YPSQ subscales with their respective negative schema counterparts. Convergent validity of the 14 subscales of YPSQ was demonstrated with measures of personality dispositions, emotional distress, well-being, trait gratitude, and humor styles. Positive schemas also showed incremental validity over and above negative schemas for these same measures, thus demonstrating that both positive and negative schemas are separate constructs that relate in unique ways to mental health. Implications for using both the YPSQ and the YSQ-S3 scales in tandem in ST as well as cultural nuances from the use of Asian samples were discussed. (PsycINFO Database Record (c) 2018 APA, all rights reserved).

Mesh:

Year:  2018        PMID: 29672073     DOI: 10.1037/pas0000567

Source DB:  PubMed          Journal:  Psychol Assess        ISSN: 1040-3590


  7 in total

1.  Development and Validation of the Young Parenting Inventory (YPI-R3) for Measuring Past Deviant and Normal Variations in Parenting.

Authors:  John P Louis; Karen M Louis; George Lockwood
Journal:  Children (Basel)       Date:  2022-05-11

2.  Predicting the role of coping factors on pandemic-related anxiety.

Authors:  Iman Askari; Lara Wenglorz; Frederik Jan Gajewski; Michaela Jänner; Alicia Vetter; Amir Askari; Samaneh Askari; Zsuzsánna Balázsy; Silke Bramer-Ugur; Dirk Reinermann; Thorsten Nolting; Eva Meisenzahl; Milenko Kujovic
Journal:  Curr Psychol       Date:  2022-05-13

3.  Psychometric validation of the Young Parenting Inventory - Revised (YPI-R2): Replication and Extension of a commonly used parenting scale in Schema Therapy (ST) research and practice.

Authors:  John Philip Louis; Alex M Wood; George Lockwood
Journal:  PLoS One       Date:  2018-11-07       Impact factor: 3.240

4.  The Good Enough Parenting early intervention schema therapy based program: Participant experience.

Authors:  John Philip Louis; Vida Ortiz; Joanna Barlas; Joyce Sue Lee; George Lockwood; Wayne Freeman Chong; Karen McDonald Louis; Patricia Sim
Journal:  PLoS One       Date:  2021-01-22       Impact factor: 3.240

5.  The effectiveness of adapted schema therapy for cluster C personality disorders in older adults - integrating positive schemas.

Authors:  L van Donzel; M A Ouwens; S P J van Alphen; S Bouwmeester; A C Videler
Journal:  Contemp Clin Trials Commun       Date:  2021-01-30

6.  The Young Parenting Inventory (YPI-R3), and the Baumrind, Maccoby and Martin Parenting Model: Finding Common Ground.

Authors:  John Philip Louis
Journal:  Children (Basel)       Date:  2022-01-26

7.  Schema therapy versus cognitive behavioral therapy versus individual supportive therapy for depression in an inpatient and day clinic setting: study protocol of the OPTIMA-RCT.

Authors:  Johannes Kopf-Beck; Petra Zimmermann; Samy Egli; Martin Rein; Nils Kappelmann; Julia Fietz; Jeanette Tamm; Katharina Rek; Susanne Lucae; Anna-Katharine Brem; Philipp Sämann; Leonhard Schilbach; Martin E Keck
Journal:  BMC Psychiatry       Date:  2020-10-14       Impact factor: 3.630

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.